US90400D1081

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

December 20, 2024 16:30 ET  | Source: Ultragenyx Pharmaceutical Inc. NOVATO, Calif., Dec. 20, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical…

20 hours ago

Ultragenyx Presents Positive Update on GTX-102 Angelman Syndrome Program at FASTs 17th Annual Global Science Summit

November 09, 2024 10:30 ET | Source: Ultragenyx Pharmaceutical Inc. Phase 1/2 data show improvements across all domains and confirm…

1 month ago